Global Pharmaceutical Glycerin Based Products Market Size, Share, and COVID-19 Impact Analysis, By Drug Type (Dermatological, Ophthalmic, Cough Remedies, Glycerine Rectal, and Angina), By Application (Glycerin as Excipient and Glycerin as Care Product), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Pharmaceutical Glycerin Based Products Market Size Insights Forecasts to 2035

• The Global Pharmaceutical Glycerin Based Products Market Size Was Estimated at USD 0.21 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 11.99% from 2025 to 2035
• The Worldwide Pharmaceutical Glycerin Based Products Market Size is Expected to Reach USD 0.73 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

The Global Pharmaceutical Glycerin-Based Products Market size was worth around USD 0.21 Billion in 2024 and is predicted to grow to around USD 0.73 Billion by 2035 with a compound annual growth rate (CAGR) of 11.99% from 2025 to 2035. The increasing demand for glycerin for the treatment of eye illnesses is driving the pharmaceutical glycerin-based products market globally.  

Market Overview

The pharmaceutical glycerin based products market refers to the market encompassing the production, distribution, and sale of products utilizing glycerin, a versatile compound derived from natural sources such as vegetable oils or animal fats. Glycerine is widely adopted in the pharmaceutical industry as it possesses various medical benefits like a moisturizer for skin burns & minor skin irritations, and cough syrups for dry cough. Glycerine is used in numerous cosmetics and personal care products like soaps, toothpaste, shaving cream, and skin/hair care products for providing smoothness and lubrication. Various benefits of glycerine, including improved smoothness, lubrication, and humectant, lead to its application in medical and pharmaceutical preparations. It is commonly used in suppositories, cough syrups, elixirs, and expectorants. An increasing demand for dermatological products, driven by growing consumer inclination towards effective and sustainable skincare solutions, is creating growth opportunities in the pharmaceutical glycerine-based products market.

Report Coverage

this research report categorizes the pharmaceutical glycerin-based products market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the pharmaceutical glycerin-based products market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the pharmaceutical glycerin-based products market.

Driving Factors

An increasing demand for glycerin for the treatment of eye illnesses is contributing to driving the pharmaceutical glycerin-based products market. Glycerol has emerged as a promising component of ophthalmic preparations, owing to its humectant, lubricant, demulcent, and Osmo protective properties. Glycerin is generally recognized as safe by regulatory authorities, like the USFDA, due to its low toxicity profile and extensive pharmaceutical use, which is driving the market. Advancements in glycerine production, including the use of genetically engineered microorganisms, advanced purification techniques, such as vacuum distillation and membrane filtration, and advances in chemical synthesis, are propelling the market growth.

Restraining Factors

Pharmaceutical glycerine adverse effects, including diarrhoea, polyuria, nausea, dry mouth, and others, are hindering the market. Unpredictable fluctuation in raw material prices is negatively impacting the purchasing behaviour among buyers, reducing the overall demand, thereby restraining the market growth.

Market Segmentation

The pharmaceutical glycerin-based products market share is classified into drug type and application.

• The dermatological segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the drug type, the pharmaceutical glycerin based products market is divided into dermatological, ophthalmic, cough remedies, glycerine rectal, and angina. Among these, the dermatological segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Glycerine is a major ingredient in moisturizers and lotions. It is commonly used with occlusive, another type of moisturizing agent, to trap the moisture it draws into the skin. An increasing demand for dermatological products among women due to the prevalence of skin diseases is contributing to driving the market.  

• The glycerine as excipient segment accounted for a dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the pharmaceutical glycerine-based products market is divided into glycerine as excipient and glycerine as care product. Among these, the glycerin as excipient segment accounted for a dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. There is an increasing demand for glycerine as a predominant excipient in pharmaceutical products, including eyewash solutions. As an excipient, glycerine aids in stabilizing formulations, enhancing the bioavailability of medicinal products, and ensuring consistent therapeutic outcomes.

Regional Segment Analysis of the Pharmaceutical Glycerin Based Products Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the pharmaceutical glycerin based products market over the predicted timeframe.

North America is anticipated to hold the largest share of the pharmaceutical glycerin based products market over the predicted timeframe. Consumer inclination towards products that align with health consciousness and the incorporation of glycerine by manufacturers as a safe alternative are driving the market. The growing demand for glycerine as a natural and non-toxic ingredient is significantly propelling the market of pharmaceutical glycerin based products.

Asia Pacific is expected to grow at a rapid CAGR in the pharmaceutical glycerin based products market during the forecast period. Expanding pharmaceutical bases within the countries of the Asia Pacific region is contributing to driving the pharmaceutical glycerin based products market. The growing awareness about natural and organic ingredients in healthcare products is propelling the market. The rising collaborations between pharmaceutical companies and research institutes, facilitating the exploration of glycerine-based therapeutic products, are promoting market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the pharmaceutical glycerin-based products market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Capsugel
• dupoint
• AbbVie Inc.
• Croda International plc.
• Emery Oleochemicals
• Johnson and Johnson
• Bausch Health Companies Inc.
• Abbott Laboratories
• Takeda Pharmaceutical Company
• The Dow Chemical Company
• Takeda Pharmaceutical Company Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In December 2022, Oleon reached a milestone in its global expansion by acquiring a blending plant in Conroe, Texas. The site would be the cornerstone for its industrial activity in the Americas with an expected initial investment of more than $50 million.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the pharmaceutical glycerin-based products market based on the below-mentioned segments: 

Global Pharmaceutical Glycerin Based Products Market, By Drug Type

• Dermatological
• Ophthalmic
• Cough Remedies
• Glycerine Rectal
• Angina

Global Pharmaceutical Glycerin Based Products Market, By Application

• Glycerin as Excipient
• Glycerin as Care Product

Global Pharmaceutical Glycerin Based Products Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa